Quantitative Evaluation of the Compatibility Effects of Huangqin Decoction on the Treatment of Irinotecan-Induced Gastrointestinal Toxicity Using Untargeted Metabolomics
Open Access
- 21 April 2017
- journal article
- research article
- Published by Frontiers Media SA in Frontiers in Pharmacology
- Vol. 8, 211
Abstract
Huangqin decoction (HQD), a traditional Chinese medicine (TCM), has been widely used to treat gastrointestinal syndrome in China for thousands of years. Chemotherapy drug irinotecan (CPT-11) is used clinically to treat various kinds of cancers but limited by its side effects, especially delayed diarrhea. Nowadays, HQD has been proved to be effective in attenuating the intestinal toxicity induced by CPT-11. HQD consists of four medicinal herbs including Scutelleria baicalensis Georgi, Glycyrrhiza uralensis Fisch, Paeonia lactiflora Pall and Ziziphus jujuba Mill. Due to its complexity, the role of each herb and the multi-herb synergistic effects of the formula are poorly understood. In order to quantitatively assess the compatibility effects of HQD, mass spectrometry-based untargeted metabolomics studies were performed. The serum metabolic profiles of rats administered with HQD, single S. baicalensis decoction, S. baicalensis-free decoction and baicalin/baicalein combination were compared. A time-dependent trajectory upon principal component analysis (PCA) was firstly used to visualize the overall differences. Then metabolites deregulation score (MDS) and relative area under the curve (RAUC) were calculated and used as parameters to quantitatively evaluate the compatibility effects of HQD from the aspect of global metabolic profile and the specifically altered metabolites, respectively. The collective results indicated that S. baicalensis played a crucial role in the therapeutic effect of HQD on irinotecan-induced diarrhea. Both HQD and SS decoction regulated glycine, serine and threonine pathway. This study demonstrated that metabolomics was a promising tool to elucidate the compatibility effects of TCM or combinatorial drugs.Keywords
Funding Information
- National Natural Science Foundation of China (81302733, 81573385)
- Program for New Century Excellent Talents in University (NCET-13-1036)
This publication has 53 references indexed in Scilit:
- Systems pharmacology in drug discovery and therapeutic insight for herbal medicinesBriefings in Bioinformatics, 2013
- Compatibility art of traditional Chinese medicine: From the perspective of herb pairsJournal of Ethnopharmacology, 2012
- Old formula, new Rx: The journey of PHY906 as cancer adjuvant therapyJournal of Ethnopharmacology, 2012
- The Four-Herb Chinese Medicine PHY906 Reduces Chemotherapy-Induced Gastrointestinal ToxicityScience Translational Medicine, 2010
- Intestinal Inflammation Increases Gastrointestinal Threonine Uptake and Mucin Synthesis in Enterally Fed MinipigsThe Journal of Nutrition, 2009
- Amino acids: metabolism, functions, and nutritionAmino Acids, 2009
- Methionine in proteins defends against oxidative stressThe FASEB Journal, 2008
- Metabonomics: a platform for studying drug toxicity and gene functionNature Reviews Drug Discovery, 2002
- Protective Effects of Kampo Medicines and Baicalin against Intestinal Toxicity of a New Anticancer Camptothecin Derivative, Irinotecan Hydrochloride (CPT‐11), in RatsJapanese Journal of Cancer Research, 1995
- Principal CurvesJournal of the American Statistical Association, 1989